Hyper Ice, Inc. et al.

Hyper Ice, Inc., commonly known as Hyperice, is a privately held American health technology company headquartered in Irvine, California, founded in 2010 by Anthony Katz. The company employs approximately 157-163 individuals and was valued at $700 million in 2020, reaching $850 million in 2024. Its estimated annual revenue was projected to exceed $200 million in 2020.

Hyperice designs and manufactures innovative recovery and movement enhancement products, leveraging technologies such as percussion, dynamic air compression, vibration, thermal, and contrast therapy. Key product lines include the Hypervolt percussion massage devices, Normatec dynamic air compression systems, Vyper and Hypersphere vibrating rollers, Venom heat and vibration devices, and Hyperice X contrast therapy systems. Hyperice's offerings are targeted at professional athletes, fitness enthusiasts, and everyday consumers, and the company serves as an official recovery partner for major sports leagues like the NBA, NFL, MLB, and UFC. They have also collaborated with Nike on wearable recovery technology like the Hyperboot.

Based on the provided case data, Hyper Ice, Inc. operates as an operating company that actively asserts its intellectual property. With one tracked case as a plaintiff and zero as a defendant, the company demonstrates a posture of enforcing its patent rights rather than primarily defending against suits. The identified litigation is in the U.S. District Court for the Central District of California, which is not typically regarded as a plaintiff-friendly venue favored by non-practicing entities (NPEs).

The notable tracked case, Hyper Ice, Inc. et al. v. Therabody, Inc., filed in the U.S. District Court for the Central District of California, is a patent infringement dispute. In this lawsuit, Hyperice, including its IP holding entity Hyperice IP Subco, LLC, asserts U.S. Patent No. 11,857,482 B1, which pertains to percussive and LED-based therapy device technology, against several of Therabody’s Theragun and TheraFace products. Therabody is a direct competitor in the wellness technology market. The case was administratively closed in 2024 for consolidation with related actions for pretrial proceedings, but Hyperice's infringement claims remain active in the consolidated matter. This litigation reflects an ongoing competitive landscape in the recovery technology sector, with Hyperice actively protecting its patented innovations.